SXSW 2021
Paving New Paths with Personalized Medicine
Description:
It’s time to make personalized medicine a priority. With the pandemic changing every fiber of our lives, and the cost of managing chronic diseases skyrocketing—now is prime time for AI-powered prevention of chronic diseases. Personalized medicine is transforming healthcare, and the market is expected to grow to more than $278B by 2030, making the technology more accessible to the general public. In this session, a panel of senior healthcare experts and visionary investors—from the US Dept of Veterans Affairs, Freenome, Rapt, and Mighty Capital—will lay out why personalized medicine is the next big innovation in healthcare, and what that will look like for consumers and the industry.
Related Media
Other Resources / Information
Takeaways
- Discover how the mobile era gave way to personalized medicine—and how the AI tech developed then is fueling the data that’s driving healthtech.
- Hear real-world examples of how personalized medicine startups like Mission Bio and Fabric Genomics are innovating healthcare.
- Discover what’s on the horizon for personalized medicine, and what predictions the panelists see in AI-powered prevention.
Speakers
- SC Moatti, Managing Partner, Mighty Capital
- Kenneth Kizer, Former Head, US Dept of Veterans Affairs
- Brian Wong, CEO, Rapt
- Asia Chang, VP Commercial Strategy & Operations, Freenome
Organizer
Katrina Cameron, Senior Associate, cred
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.
Add Comments